Physician profile
Daniel Torres
NPI 1972738979
$7,817.98
in general payments reported to CMS, 2019-2025
26 companies · $2,773 in 2025
The $2,773 reported for 2025 was more than what 86% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,362 · 2020: $125 · 2021: $2,502 · 2022: $453 · 2023: $482 · 2024: $120 · 2025: $2,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,945 · Food and Beverage: $1,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,944.86 |
| Food and Beverage | $1,430.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $2,206.82 | 2019-2021 | |
| Axogen | $2,118.36 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Medartis INC. | $972.03 | 2025 | Aptus |
| Arthrex, INC. | $409.16 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $355.91 | 2019-2023 | Xiaflex |
| Stryker Corporation | $276.66 | 2021-2025 | Gamma, Pangea |
| Novus Surgical Solutions LLC | $216.60 | 2019-2022 | |
| Acumed LLC | $173.66 | 2019-2023 | Acumed, Innate Implant |
| Horizon Therapeutics Plc | $145.58 | 2021-2023 | Krystexxa |
| Novus Surgical Consultants | $144.81 | 2023-2024 | |
| Depuy Synthes Sales INC. | $136.75 | 2019-2025 | Tfn-Advance |
| Integra Lifesciences Corporation | $93.36 | 2019-2021 | |
| Djo, LLC | $81.70 | 2021 | |
| Medinc of Texas | $81.40 | 2025 | |
| Anika Therapeutics, INC. | $79.26 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $61.03 | 2023 | Cimzia |
| Alafair Biosciences, INC. | $52.00 | 2022 | |
| Arthrosurface Incorporated | $47.89 | 2025 | Wristmotion Wrist Hemiarthroplasty System, Ovomotion |
| Amgen INC. | $40.77 | 2021-2022 | |
| Smith+Nephew, INC. | $29.31 | 2025 | Bone Anchors With Arthroscopic Delivery System, Spyromite |
| Ermi LLC | $19.71 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $19.59 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.20 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.46 | 2023 | Euflexxa |
| Fidia Pharma USA INC. | $14.41 | 2023 | Hymovis |
| Orthofix Medical, INC. | $9.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.